Research Without Animals
Epidemiologic and Clinical Studies
Studies of human populations have provided important information
about the causes of many diseases, such as the relationships between
cholesterol and heart disease, the mechanism of transmission of
HIV, and chemical exposures and birth defects.
Scientists can “see” abnormalities—and track
treatment progress—in the brains of victims of Alzheimer’s
and Parkinson’s diseases, schizophrenia, epilepsy, and brain
injury1 using sophisticated scanning technologies (CT, PET, and
MRI). All drugs must undergo clinical testing before becoming approved;
carefully crafted clinical research is the best way to determine
human reactions to new drugs.
In Vitro Research
An enormous amount of valuable in vitro (test
tube) research is conducted today. The National Disease Research
Interchange provides more than 130 kinds of human tissue to scientists
investigating more than 50 diseases, including cancer, diabetes,
and glaucoma. Cell and tissue cultures are used to screen new therapies
and to test for product safety. Genetic microarrays are being used
to predict liver toxicity by measuring gene expression in human
liver cells.2
In Silico (Computer) Technologies
Computers can often predict the
toxicity of chemicals, including their potential to cause cancer
or birth defects, based on their molecular structure. Computer
simulations can also predict the metabolism and distribution of
chemicals in human tissues.
Safety Testing
Safety tests using human cells are more accurate
than animal tests. In the Multicenter Evaluation of In Vitro Cytotoxicity
tests (MEIC), researchers evaluated 68 different methods to predict
the toxicity of 50 different chemicals.3 Rat LD50 tests4—lethal
dose tests currently used—were only 59 percent accurate,
but a combined human cell test was 83 percent accurate in predicting
actual human toxicity.5,6
Pharmagene Laboratories conducts new drug development exclusively
using human tissues and computer technologies. With tools from
molecular biology and biochemistry, Pharmagene investigates how
new drugs affect the actions of human genes or the proteins they
make. These techniques replace animal tests in many cases.
References
1. Langley G et al. ATLA 2000;28:315-331.
2. Kier et al. Mutat Res.
2004 May 18;549(1-2):101-13.
3. PCRM fact sheet, In Vitro Acute Toxicity Tests More Predictive
Than Animal Tests.
4. PCRM fact sheet, Inadequacy of the LD50 Test.
5.
PCRM fact sheet Rats:
Test Results That Don’t Apply
to Humans.
6. Clemedson C et al. ATLA 1996; 24:273-311.
Media
Center | Health | Research
| About PCRM | Catalog
| Join Us | Search
| Site Index | Home
The site does
not provide medical or legal advice. This Web site is for information purposes
only.
Full Disclaimer | Privacy Policy
|